Product Code: TMRGL84628
Scope of the Report
TMR's report on the global albumin market studies the past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides revenue of the global albumin market for the period 2017-2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global albumin market during the forecast period.
The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the global albumin market.
Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global albumin market.
The report includes an elaborate executive summary along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global albumin market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global albumin market.
The report delves into the competitive landscape of the global albumin market. Key players operating in the global albumin market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global albumin market that have been profiled in this report.
Key Questions Answered:
- What is the scope of growth of product companies in the global albumin market?
- What will be the Y-o-Y growth of the global albumin market between 2017 and 2031?
- What is the influence of changing trends in technologies on the global albumin market?
- Will Asia Pacific be the most profitable market for albumin providers?
- Which factors are anticipated to hamper the growth of the global albumin market during the forecast period?
- Which are the leading companies in the global albumin market?
Research Methodology
TMR has utilized a unique research methodology to conduct comprehensive research on the growth of the global albumin market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.
Secondary methods referred to by analysts during the production of the global albumin market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR's study on the albumin market as primary methods.
These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the albumin market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global albumin market with accuracy. The study also uses the top-down approach to assess the revenue for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR's estimates on future prospects of the global albumin market more reliably and accurately.
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Albumin Market
4. Market Overview
- 4.1. Introduction
- 4.1.1. Definition
- 4.1.2. Industry Evolution / Developments
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Albumin Market Analysis and Forecast, 2017-2031
5. Key Insights
- 5.1. Key Industry Events (mergers, acquisitions, partnerships, etc.)
- 5.2. Regulatory Scenario by Key Countries
- 5.3. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Albumin Market Analysis and Forecast, by Product
- 6.1. Introduction & Definition
- 6.2. Key Findings / Developments
- 6.3. Market Value Forecast, by Product, 2017-2031
- 6.3.1. Human Serum Albumin
- 6.3.2. Recombinant Albumin
- 6.4. Market Attractiveness Analysis, by Product
7. Global Albumin Market Analysis and Forecasts, by Application
- 7.1. Introduction & Definition
- 7.2. Key Findings / Developments
- 7.3. Market Value Forecast, by Application, 2017-2031
- 7.3.1. Human Serum Albumin Applications
- 7.3.1.1. Drug Formulation
- 7.3.1.2. Drug Delivery
- 7.3.1.3. Vaccines
- 7.3.1.4. Medical Device Coating
- 7.3.1.5. Culture Media & Stabilizers
- 7.3.1.6. Diagnostics
- 7.3.1.7. In Vitro Fertilization
- 7.3.2. Recombinant Albumin Applications
- 7.3.2.1. Drug Formulation
- 7.3.2.2. Drug Delivery
- 7.3.2.3. Vaccines
- 7.3.2.4. Medical Device Coating
- 7.3.2.5. Culture Media & Stabilizers
- 7.3.2.6. Diagnostics
- 7.3.2.7. In Vitro Fertilization
8. Global Albumin Market Analysis and Forecast, by End-user
- 8.1. Introduction & Definition
- 8.2. Key Findings / Developments
- 8.3. Market Value Forecast, by End-user, 2017-2031
- 8.3.1. Pharmaceutical & Biotechnology Companies
- 8.3.2. Research Institutes
- 8.3.3. Others
- 8.4. Market Attractiveness Analysis, by End-user
9. Global Albumin Market Analysis and Forecast, by Region
- 9.1. Key Findings
- 9.2. Market Value Forecast, by Region
- 9.2.1. North America
- 9.2.2. Europe
- 9.2.3. Asia Pacific
- 9.2.4. Latin America
- 9.2.5. Middle East & Africa
10. North America Albumin Market Analysis and Forecast
- 10.1. Introduction
- 10.2. Market Value Forecast, by Product, 2017-2031
- 10.2.1. Human Serum Albumin
- 10.2.2. Recombinant Albumin
- 10.3. Market Value Forecast, by Application, 2017-2031
- 10.3.1. Human Serum Albumin Applications
- 10.3.1.1. Drug Formulation
- 10.3.1.2. Drug Delivery
- 10.3.1.3. Vaccines
- 10.3.1.4. Medical Device Coating
- 10.3.1.5. Culture Media & Stabilizers
- 10.3.1.6. Diagnostics
- 10.3.1.7. In Vitro Fertilization
- 10.3.2. Recombinant Albumin Applications
- 10.3.2.1. Drug Formulation
- 10.3.2.2. Drug Delivery
- 10.3.2.3. Vaccines
- 10.3.2.4. Medical Device Coating
- 10.3.2.5. Culture Media & Stabilizers
- 10.3.2.6. Diagnostics
- 10.3.2.7. In Vitro Fertilization
- 10.4. Market Value Forecast, by End-user, 2017-2031
- 10.4.1. Pharmaceutical & Biotechnology Companies
- 10.4.2. Research Institutes
- 10.4.3. Others
- 10.5. Market Value Forecast, by Country, 2017-2031
- 10.5.1. U.S.
- 10.5.2. Canada
- 10.6. Market Attractiveness Analysis
- 10.6.1. By Product
- 10.6.2. By Application
- 10.6.3. By End-user
- 10.6.4. By Country
11. Europe Albumin Market Analysis and Forecast
- 11.1. Introduction
- 11.2. Market Value Forecast, by Product, 2017-2031
- 11.2.1. Human Serum Albumin
- 11.2.2. Recombinant Albumin
- 11.3. Market Value Forecast, by Application, 2017-2031
- 11.3.1. Human Serum Albumin Applications
- 11.3.1.1. Drug Formulation
- 11.3.1.2. Drug Delivery
- 11.3.1.3. Vaccines
- 11.3.1.4. Medical Device Coating
- 11.3.1.5. Culture Media & Stabilizers
- 11.3.1.6. Diagnostics
- 11.3.1.7. In Vitro Fertilization
- 11.3.2. Recombinant Albumin Applications
- 11.3.2.1. Drug Formulation
- 11.3.2.2. Drug Delivery
- 11.3.2.3. Vaccines
- 11.3.2.4. Medical Device Coating
- 11.3.2.5. Culture Media & Stabilizers
- 11.3.2.6. Diagnostics
- 11.3.2.7. In Vitro Fertilization
- 11.4. Market Value Forecast, by End-user, 2017-2031
- 11.4.1. Pharmaceutical & Biotechnology Companies
- 11.4.2. Research Institutes
- 11.4.3. Others
- 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 11.5.1. Germany
- 11.5.2. U.K.
- 11.5.3. France
- 11.5.4. Italy
- 11.5.5. Spain
- 11.5.6. Rest of Europe
- 11.6. Market Attractiveness Analysis
- 11.6.1. By Product
- 11.6.2. By End-user
- 11.6.3. By Country/Sub-region
12. Asia Pacific Albumin Market Analysis and Forecast
- 12.1. Introduction
- 12.2. Market Value Forecast, by Product, 2017-2031
- 12.2.1. Human Serum Albumin
- 12.2.2. Recombinant Albumin
- 12.3. Market Value Forecast by Application, 2017-2031
- 12.3.1. Human Serum Albumin Applications
- 12.3.1.1. Drug Formulation
- 12.3.1.2. Drug Delivery
- 12.3.1.3. Vaccines
- 12.3.1.4. Medical Device Coating
- 12.3.1.5. Culture Media & Stabilizers
- 12.3.1.6. Diagnostics
- 12.3.1.7. In Vitro Fertilization
- 12.3.2. Recombinant Albumin Applications
- 12.3.2.1. Drug Formulation
- 12.3.2.2. Drug Delivery
- 12.3.2.3. Vaccines
- 12.3.2.4. Medical Device Coating
- 12.3.2.5. Culture Media & Stabilizers
- 12.3.2.6. Diagnostics
- 12.3.2.7. In Vitro Fertilization
- 12.4. Market Value Forecast, by Product, 2017-2031
- 12.4.1. Pharmaceutical & Biotechnology Companies
- 12.4.2. Research Institutes
- 12.4.3. Others
- 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 12.5.1. China
- 12.5.2. Japan
- 12.5.3. South Korea
- 12.5.4. India
- 12.5.5. Australia & New Zealand
- 12.5.6. Rest of Asia Pacific
- 12.6. Market Attractiveness Analysis
- 12.6.1. By Product
- 12.6.2. By Application
- 12.6.3. By End-user
- 12.6.4. By Country/Sub-region
13. Latin America Albumin Market Analysis and Forecast
- 13.1. Introduction
- 13.2. Market Value Forecast, by Product, 2017-2031
- 13.2.1. Human Serum Albumin
- 13.2.2. Recombinant Albumin
- 13.3. Market Value Forecast by Application, 2017-2031
- 13.3.1. Human Serum Albumin Applications
- 13.3.1.1. Drug Formulation
- 13.3.1.2. Drug Delivery
- 13.3.1.3. Vaccines
- 13.3.1.4. Medical Device Coating
- 13.3.1.5. Culture Media & Stabilizers
- 13.3.1.6. Diagnostics
- 13.3.1.7. In Vitro Fertilization
- 13.3.2. Recombinant Albumin Applications
- 13.3.2.1. Drug Formulation
- 13.3.3. Drug Delivery
- 13.3.3.1. Vaccines
- 13.3.3.2. Medical Device Coating
- 13.3.3.3. Culture Media & Stabilizers
- 13.3.3.4. Diagnostics
- 13.3.3.5. In Vitro Fertilization
- 13.4. Market Value Forecast, by End-user, 2017-2031
- 13.4.1. Pharmaceutical & Biotechnology Companies
- 13.4.2. Research Institutes
- 13.4.3. Others
- 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 13.5.1. Brazil
- 13.5.2. Mexico
- 13.5.3. Rest of Latin America
- 13.6. Market Attractiveness Analysis
- 13.6.1. By Product
- 13.6.2. By Application
- 13.6.3. By End-user
- 13.6.4. By Country/Sub-region
14. Middle East & Africa Albumin Market Analysis and Forecast
- 14.1. Introduction
- 14.2. Market Value Forecast, by Product, 2017-2031
- 14.2.1. Human Serum Albumin
- 14.2.2. Recombinant Albumin
- 14.3. Market Value Forecast, by End-user, 2017-2031
- 14.3.1. Pharmaceutical & Biotechnology Companies
- 14.3.2. Research Institutes
- 14.3.3. Others
- 14.4. Market Value Forecast, by Country/Sub-region, 2017-2031
- 14.4.1. GCC Countries
- 14.4.2. South Africa
- 14.4.3. Rest of Middle East & Africa
- 14.5. Market Attractiveness Analysis
- 14.5.1. By Product
- 14.5.2. By Application
- 14.5.3. By End-user
- 14.5.4. By Country/Sub-region
15. Competition Landscape
- 15.1. Market Player - Competition Matrix (by tier and size of companies)
- 15.2. Market Share Analysis, by Company, 2020
- 15.3. Company Profiles
- 15.3.1. Albumedix A/S
- 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.1.2. Financial Analysis
- 15.3.1.3. Growth Strategies
- 15.3.1.4. SWOT Analysis
- 15.3.2. Albumin Therapeutics, LLC
- 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.2.2. Financial Analysis
- 15.3.2.3. Growth Strategies
- 15.3.2.4. SWOT Analysis
- 15.3.3. Biotest AG
- 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.3.2. Financial Analysis
- 15.3.3.3. Growth Strategies
- 15.3.3.4. SWOT Analysis
- 15.3.4. CSL Behring LLC
- 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.4.2. Financial Analysis
- 15.3.4.3. Growth Strategies
- 15.3.4.4. SWOT Analysis
- 15.3.5. Grifols International, S.A.
- 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.5.2. Financial Analysis
- 15.3.5.3. Growth Strategies
- 15.3.5.4. SWOT Analysis
- 15.3.6. HiMedia Laboratories Pvt. Ltd.
- 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.6.2. Financial Analysis
- 15.3.6.3. Growth Strategies
- 15.3.6.4. SWOT Analysis
- 15.3.7. InVitria
- 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.7.2. Financial Analysis
- 15.3.7.3. Growth Strategies
- 15.3.7.4. SWOT Analysis
- 15.3.8. Medxbio Pte Ltd.
- 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.8.2. Financial Analysis
- 15.3.8.3. Growth Strategies
- 15.3.8.4. SWOT Analysis
- 15.3.9. Octapharma AG
- 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.9.2. Financial Analysis
- 15.3.9.3. Growth Strategies
- 15.3.9.4. SWOT Analysis
- 15.3.10. RayBiotech, Inc.
- 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.10.2. Financial Analysis
- 15.3.10.3. Growth Strategies
- 15.3.10.4. SWOT Analysis
- 15.3.11. Seracare Life Sciences (LGC)
- 15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.11.2. Financial Analysis
- 15.3.11.3. Growth Strategies
- 15.3.11.4. SWOT Analysis
- 15.3.11.5. SWOT Analysis
- 15.3.12. Sigma-Aldrich Co. (Merck KGaA)
- 15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.12.2. Financial Analysis
- 15.3.12.3. Growth Strategies
- 15.3.12.4. SWOT Analysis
- 15.3.13. Takeda Pharmaceutical Company Limited (Shire)
- 15.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.13.2. Financial Analysis
- 15.3.13.3. Growth Strategies
- 15.3.13.4. SWOT Analysis